These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2745033)

  • 41. Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical response.
    Levy T; Weiser R; Boaz M; Shem EB; Golan A; Menczer J
    Int J Gynecol Cancer; 2012 Oct; 22(8):1344-8. PubMed ID: 22954785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
    Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
    Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
    van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
    Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Value of serum CA(125) detection for predicting recurrence and prognosis in ovarian epithelial cancer].
    Wang XY; Ye J; Feng SW; Lü WG; Wan XY; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):813-6. PubMed ID: 21211277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer.
    Niloff JM; Knapp RC; Lavin PT; Malkasian GD; Berek JS; Mortel R; Whitney C; Zurawski VR; Bast RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):56-60. PubMed ID: 3460341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1993 Apr; 49(1):3-7. PubMed ID: 8482556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
    Bidart JM; Bellet D
    Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
    van Dalen A; Favier J; Burges A; Hasholzner U; de Bruijn HW; Dobler-Girdziunaite D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Bowman A; Einarsson R
    Gynecol Oncol; 2000 Dec; 79(3):444-50. PubMed ID: 11104617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma.
    Högberg T; Kågedal B
    Acta Obstet Gynecol Scand; 1990; 69(5):423-9. PubMed ID: 2270768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.
    Makar AP; Kristensen GB; Kaern J; Børmer OP; Abeler VM; Tropé CG
    Obstet Gynecol; 1992 Jun; 79(6):1002-10. PubMed ID: 1579296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer.
    Zurawski VR; Orjaseter H; Andersen A; Jellum E
    Int J Cancer; 1988 Nov; 42(5):677-80. PubMed ID: 3182103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.
    Gallion HH; Hunter JE; van Nagell JR; Averette HE; Cain JM; Copeland LJ; Higgins RV; Husseinzadeh N; Nahhas WA; Partridge EE
    Gynecol Oncol; 1992 Jul; 46(1):29-32. PubMed ID: 1634137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction.
    Hunter VJ; Daly L; Helms M; Soper JT; Berchuck A; Clarke-Pearson DL; Bast RC
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1164-7. PubMed ID: 2171337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer.
    Mogensen O; Mogensen B; Jakobsen A
    Gynecol Oncol; 1990 Apr; 37(1):44-6. PubMed ID: 2323611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
    Miladinović D; Paunović R; Paunković N
    Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The management of ovarian carcinoma is improved by the use of cancer-associated serum antigen and CA 125 assays.
    Ward BG; McGuckin MA; Ramm LE; Coglan M; Sanderson B; Tripcony L; Free KE
    Cancer; 1993 Jan; 71(2):430-8. PubMed ID: 8422635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F; Vavra N; Kurz C; Sevelda P
    Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.